Formulation and In Vitro Studies of a Fixed-Dose Combination of a Bilayer Matrix Tablet Containing Metformin HCl as Sustained Release and Glipizide as Immediate Release

Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.
Drug Development and Industrial Pharmacy (Impact Factor: 2.1). 04/2008; 34(3):305-13. DOI: 10.1080/03639040701657487
Source: PubMed


The emerging new fixed dose combination of metformin hydrocholride (HCl) as sustained release and glipizide as immediate release were formulated as a bilayer matrix tablet using hydroxy propyl methyl cellulose (HPMC) as the matrix-forming polymer, and the tablets were evaluated via in vitro studies. Three different grades of HPMC (HPMC K 4M, HPMC K 15M, and HPMC K 100M) were used. All tablet formulations yielded quality matrix preparations with satisfactory tableting properties. In vitro release studies were carried out at a phosphate buffer of pH 6.8 with 0.75% sodium lauryl sulphate w/v using the apparatus I (basket) as described in the 25.
United States Pharmacopeia. United States pharmacopeia–national formulary. United States Pharmacopeial Convention, Rockville 2000, (USP 24/NF 19)View all references. The release kinetics of metformin were evaluated using the regression coefficient analysis. There was no significant difference in drug release for different viscosity grade of HPMC with the same concentration. Tablet thus formulated provided sustained release of metformin HCl over a period of 8 hours and glipizide as immediate release.

Download full-text


Available from: Uttam Kumar Mandal, Sep 19, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, we establish a theoretical framework for a new concept of scheduling called soft scheduling. In contrasts to the traditional schedulers referred as hard schedulers, soft schedulers make soft decisions at a time, or decisions that can be adjusted later. Soft scheduling has a potential to alleviate the phase coupling problem that has plagued traditional high level synthesis (HLS), HLS for deep submicron design and VLIW code generation. We then develop a specific soft scheduling formulation, called threaded schedule, under which a linear, optimal (in the sense of online optimality) algorithm is guaranteed
    Full-text · Conference Paper · Feb 1999
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Genetic mapping studies have suggested that diploid cotton (Gossypium) might be an ancient polyploid. However, further evidence is lacking due to the complexity of the genome and the lack of sequence resources. Here, we used the grape (Vitis vinifera) genome as an out-group in two different approaches to further explore evidence regarding ancient genome duplication (WGD) event(s) in the diploid Gossypium lineage and its (their) effects: a genome-level alignment analysis and a local-level sequence component analysis. Both studies suggest that at least one round of genome duplication occurred in the Gossypium lineage. Also, gene densities in corresponding regions from Gossypium raimondii, V. vinifera, Arabidopsis thaliana and Carica papaya genomes are similar, despite the huge difference in their genome sizes and the different number of WGDs each genome has experienced. These observations fit the model that differences in plant genome sizes are largely explained by transposon insertions into heterochromatic regions.
    Full-text · Article · Feb 2011 · Genomics
  • [Show abstract] [Hide abstract]
    ABSTRACT: Digestive disorders (diarrhoea, vomiting) represent the most common metformin side-effects (around 30%) with this first-line drug treatment for type 2 diabetes. In healthy individuals, metformin affects glucose, vitamin B12 and the digestive uptake of bile salts. In the colon, it acts locally by modifying glucose cell metabolism. Different pathophysiological hypotheses have been proposed to explain the metformin-induced diarrhoea and vomiting, which can sometimes cause the patient to stop an effective treatment. These theories include stimulation of intestinal secretion of serotonin, changes in incretin and glucose metabolism, and bile-salt malabsorption. However, none of these hypotheses can be considered an adequate pathophysiological explanation of metformin digestive side-effects. In addition, there is a lack of experimental data to explain these highly patient-dependent adverse effects.
    No preview · Article · Apr 2011 · Diabetes & Metabolism
Show more